Showing results (131-140 of 188) with videos related to
Sort By:
Pageof 19
Surgery Today|March 27, 2010
Mediastinal metastasis from a fibrolamellar hepatocellular carcinoma: Report of a caseYoshinobu Ichiki, Kenji Sugio, Tetsuro Baba, et al.Anticancer Research|November 11, 2006
Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancerManabu Yasuda, Makiko Mizukami, Takeshi Hanagiri, et al.Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Hazardous environmental factors enhance impairment of liver function in HBV and HCV hepatitisYasunori Yashima, Tsunehiro Oyama, Thi Thu Phuong Pham, et al.Cancer Science|December 22, 2005
Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical courseMakiko Mizukami, Takeshi Hanagiri, Tetsuro Baba, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Clinical characterization of node-negative lung adenocarcinoma: results of a prospective investigationIchiro Yoshino, Yukito Ichinose, Akira Nagashima, et al.The Oncologist|July 13, 2020
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101)Kaname Nosaki, Takeharu Yamanaka, Akinobu Hamada, et al.Internal Medicine (Tokyo, Japan)|March 16, 2010
Incidentally proven pulmonary "ALKoma"Atsushi Osoegawa, Kaname Nosaki, Hitoshi Miyamoto, et al.The Annals of Thoracic Surgery|September 4, 2013
Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancerMasafumi Yamaguchi, Gouji Toyokawa, Taro Ohba, et al.International Journal of Cancer|September 25, 2003
Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancersArvind Virmani, Asha Rathi, Shashank Heda, et al.Cancer Science|May 20, 2014
Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology GroupHaruyasu Murakami, Takeharu Yamanaka, Takashi Seto, et al.Pageof 19